Patent Assignment
Reel/Frame 069769/0320
Merger
Recorded: 2025-01-07
Pages: 5
Assignor
ARIAD PHARMACEUTICALS, INC.
Executed: 2024-12-24
Assignee
TAKEDA PHARMACEUTICALS U.S.A., INC.
500 KENDALL STREET, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties
(20)
Substituted acetylenic imidazo[1,2-B]pyridazine compounds as kinase inhibitors
Substituted Acetylenic Imidazo[1,2-a]Pyridine Compounds as Kinase Inhibitors
Substituted Acetylenic Imidazo[1,2-a]Pyridazines as Kinase INHIB1TORS
Substituted Acetylenic Imidazo[1,2-a]Pyrazine Compounds as Kinase Inhibitors
SUBSTITUTED ACETYLENIC PYRAZOLO[1,5-a]PYRIMIDINES AS KINASE INHIBITORS
Crystalline Forms of 3-(Imidazo[1,2-B] Pyridazin-3-Ylethynyl)-4-Methyl-N-{4-[(4-Methylpiperazin-1-Yl)Methyl]-3-(Trifluoromethyl)Phenyl}Benzamide and Its Mono Hydrochloride Salt
Crystalline Forms of 3-(Imidazo[1,2-B] Pyridazin-3-Ylethynyl)-4-Methyl-N-{4-[(4-Methylpiperazin-1-Yl)Methyl]-3-(Trifluoromethyl)Phenyl}Benzamide and Its Mono Hydrochloride Salt
Crystalline Forms of 3-(Imidazo[1,2-B]Pyridazin-3-Ylethynyl)-4-Methyl-N-{4-[(4-Methylpiperazin-1-Yl)Methyl]-3-(Trifluoromethyl)Phenyl}Benzamide and Its Mono Hydrochloride Salt
Anilinopyrimidines as Haematopoietic Progenitor Kinase 1 (HPK1) Inhibitors
Aminothiazole Compounds as C-Kit Inhibitors
Crystalline Forms of 3-(Imidazo[1,2-B]Pyridazin-3-Ylethynyl)-4-Methyl-N-{4-[(4-Methylpiperazin-1-Yl)Methyl]-3-(Trifluoromethyl)Phenyl}Benzamide and Its Mono Hydrochloride Salt
Aminothiazole Compounds as C-Kit Inhibitors
Crystalline Forms of 3-(Imidazo[1,2-B]Pyridazin-3-Ylethynyl)-4-Methyl-N-{4-[(4-Methylpiperazin-1-Yl)Methyl]-3-(Trifluoromethyl)Phenyl}Benzamide and Its Mono Hydrochloride Salt
Crystalline Forms of 3-(Imidazo[1,2-B]Pyridazin-3-Ylethynyl)-4-Methyl-N-{4-[(4-Methylpiperazin-1-Yl)Methyl]-3-(Trifluoromethyl)Phenyl}Benzamide and Its Mono Hydrochloride Salt
Crystalline Forms of 3-(Imidazo[1,2-B]Pyridazin-3-Ylethynyl)-4-Methyl-N-{4-[(4-Methylpiperazin-1-Yl)Methyl]-3-(Trifluoromethyl)Phenyl}Benzamide and Its Mono Hydrochloride Salt
Crystalline Forms of 3-(Imidazo[1,2-B]Pyridazin-3-Ylethynyl)-4-Methyl-N-{4-[(4-Methylpiperazin-1-Yl)Methyl]-3-(Trifluoromethyl)Phenyl}Benzamide and Its Mono Hydrochloride Salt
Substituted Acetylenic Pyrazolo[1,5-a]Pyridine Compounds as Kinase Inhibitors
Application:
17/498,796 →
Publication:
US 2022/0081440
Crystalline Forms of 3-(Imidazo[1,2-B]Pyridazin-3-Ylethynyl)-4-Methyl-N-{4-[(4-Methylpiperazin-1-Yl)Methyl]-3-(Trifluoromethyl)Phenyl}Benzamide and Its Mono Hydrochloride Salt
Application:
18/175,272 →
Publication:
US 2024/0083902
Aminothiazole Compounds as C-Kit Inhibitors
Application:
18/361,430 →
Publication:
US 2024/0208960
Substituted Acetylenic Pyrazolo[1,5-a]Pyridine Compounds as Kinase Inhibitors
Application:
18/763,056 →
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 16, 2007
From: ZOU, DONG; HUANG, WEI-SHENG; THOMAS, R. MATHEW; ROMERO, JAN ANTOINETTE C.
To: ARIAD PHARMACEUTICALS, INC.
Reel/Frame 019199/0256 →
Assignment of Assignor's Interest
Jan 29, 2015
From: ZOU, DONG; HUANG, WEI-SHENG; THOMAS, R. MATHEW; ROMERO, JAN ANTOINETTE C.
To: ARIAD PHARMACEUTICALS, INC.
Reel/Frame 034844/0032 →
Assignment of Assignor's Interest
Jan 29, 2015
From: ZOU, DONG; HUANG, WEI-SHENG; THOMAS, R. MATHEW; ROMERO, JAN ANTOINETTE C.
To: ARIAD PHARMACEUTICALS, INC.
Reel/Frame 034845/0682 →
Assignment of Assignor's Interest
Jan 29, 2015
From: ZOU, DONG; HUANG, WEI-SHENG; THOMAS, R. MATHEW; ROMERO, JAN ANTOINETTE C.
To: ARIAD PHARMACEUTICALS, INC.
Reel/Frame 034844/0551 →
Assignment of Assignor's Interest
Jan 29, 2015
From: ZOU, DONG; HUANG, WEI-SHENG; THOMAS, R. MATHEW; ROMERO, JAN ANTOINETTE C.
To: ARIAD PHARMACEUTICALS, INC.
Reel/Frame 034844/0284 →
Assignment of Assignor's Interest
Jan 7, 2016
From: MURRAY, CHRISTOPHER K.; ROZAMUS, LEONARD W.; CHABER, JOHN J.; SHARMA, PRADEEP
To: ARIAD PHARMACEUTICALS, INC.
Reel/Frame 037431/0329 →
Assignment of Assignor's Interest
Nov 11, 2016
From: MURRAY, CHRISTOPHER K.; ROZAMUS, LEONARD W.; CHABER, JOHN J.; SHARMA, PRADEEP
To: ARIAD PHARMACEUTICALS, INC.
Reel/Frame 040283/0928 →
Assignment of Assignor's Interest
Nov 6, 2018
From: MURRAY, CHRISTOPHER K.; ROZAMUS, LEONARD W.; CHABER, JOHN J.; SHARMA, PRADEEP
To: ARIAD PHARMACEUTICALS, INC.
Reel/Frame 047422/0016 →
Assignment of Assignor's Interest
May 22, 2020
From: MURRAY, CHRISTOPHER K.; ROZAMUS, LEONARD W.; CHABER, JOHN J.; SHARMA, PRADEEP
To: ARIAD PHARMACEUTICALS, INC.
Reel/Frame 052736/0432 →
Assignment of Assignor's Interest
Aug 17, 2020
From: BENCIVENGA, NICHOLAS E.; DALGARNO, DAVID C.; GOZGIT, JOSEPH M.; HUANG, WEI-SHENG
To: ARIAD PHARMACEUTICALS, INC.
Reel/Frame 053507/0983 →
Assignment of Assignor's Interest
Jul 2, 2021
From: BENCIVENGA, NICHOLAS E.; DALGARNO, DAVID C.; GOZGIT, JOSEPH M.; HUANG, WEI-SHENG
To: ARIAD PHARMACEUTICALS, INC.
Reel/Frame 056747/0386 →